Mounjaro (Tirzepatide) is a weight loss drug that acts on both GLP-1 and GIP receptors
Additional safety considerations include: risk of hypoglycemia when used with insulin or sulfonylureas (dose adjustments may be needed)
However, based on anecdotal evidence, nutrition scientists have come up with working definitions to facilitate research on the subject
M., Carreira, J
CagriSema vs MariTide: How the Two Upcoming Shots Compare CagriSema and MariTide are both weight-loss injectables working their way toward the market, but theyre at different stages and use different designs
7 Still, Le, who is also a general surgery registrar at Royal Melbourne Hospital, says, I think it is too early to say this is a robust, durable, and generalizable effect given the high heterogeneity of underlying studies. He notes a need for more rigorous randomized controlled trials with longer follow-up times to better characterize the impact of these medications on weight and OSA together, as well as gain a better understanding of effect size, optimal doses, side effects, interactions with other medications, and impacts on other comorbidities
